Illumina to Provide NGS Technologies to LabCorp
Illumina Inc. has entered into a multi-year supply agreement giving LabCorp expanded rights to use Illumina next-generation sequencing and microarray equipment and supplies.
Read MoreSearch Results for: genetic testing
Leading Edge Developments in Point-of-Care Testing
Lab adoption and applications for POC testing are continuing to expand.
Read More
From the Editor: January 2014: New Year, Familiar Logjam?
So far as the realm of molecular diagnostics is concerned, 2013 may go into the books as a year of some significance. But further developments in the coming year could ultimately turn out to be even more important.
Read MoreMolecularHealth Partners with GATC Biotech for Genetic Sequencing Technology and Expertise
Molecular Health has joined with GATC Biotech to obtain laboratory information management systems, training, and protocols to support MolecularHealth’s oncology testing and treatment decision support platform.
Read More
Insight Genetics Gets New NCI Contract to Identify Resistance Mutations in Lung Cancer Patients
The National Cancer Institute has awarded Insight Genetics a $1.5 million Phase II continuation of its SBIR contract for developing a companion diagnostic to assess patient resistance to therapies for non-small cell lung cancer.
Read More